These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

529 related items for PubMed ID: 2512330

  • 1. Nonopsonic antibodies in cystic fibrosis. Pseudomonas aeruginosa lipopolysaccharide-specific immunoglobulin G antibodies from infected patient sera inhibit neutrophil oxidative responses.
    Eichler I, Joris L, Hsu YP, Van Wye J, Bram R, Moss R.
    J Clin Invest; 1989 Dec; 84(6):1794-804. PubMed ID: 2512330
    [Abstract] [Full Text] [Related]

  • 2. Lipopolysaccharide (LPS), LPS-immune complexes and cytokines as inducers of pulmonary inflammation in patients with cystic fibrosis and chronic Pseudomonas aeruginosa lung infection.
    Kronborg G.
    APMIS Suppl; 1995 Dec; 50():1-30. PubMed ID: 7756034
    [Abstract] [Full Text] [Related]

  • 3. Serotype-specific serum IgG antibodies to lipopolysaccharides of Pseudomonas aeruginosa in cystic fibrosis: correlation to disease, subclass distribution, and experimental protective capacity.
    Schaad UB, Lang AB, Wedgwood J, Buehlamnn U, Fuerer E.
    Pediatr Res; 1990 May; 27(5):508-13. PubMed ID: 2111907
    [Abstract] [Full Text] [Related]

  • 4. Opsonization of mucoid and non-mucoid Pseudomonas aeruginosa by serum from patients with cystic fibrosis assessed by a chemiluminescence assay.
    LeBlanc CM, Bortolussi R, Issekutz AC, Gillespie T.
    Clin Invest Med; 1982 May; 5(2-3):125-8. PubMed ID: 6811181
    [Abstract] [Full Text] [Related]

  • 5. Altered antibody isotype in cystic fibrosis: possible role in opsonic deficiency.
    Moss RB, Hsu YP, Sullivan MM, Lewiston NJ.
    Pediatr Res; 1986 May; 20(5):453-9. PubMed ID: 3714355
    [Abstract] [Full Text] [Related]

  • 6. Immunoglobulin allotypes and IgG subclass antibody response to Pseudomonas aeruginosa antigens in chronically infected cystic fibrosis patients.
    Pressler T, Pandey JP, Espersen F, Pedersen SS, Fomsgaard A, Koch C, Høiby N.
    Clin Exp Immunol; 1992 Nov; 90(2):209-14. PubMed ID: 1424275
    [Abstract] [Full Text] [Related]

  • 7. Functional importance of cystic fibrosis immunoglobulin G fragments generated by Pseudomonas aeruginosa elastase.
    Bainbridge T, Fick RB.
    J Lab Clin Med; 1989 Dec; 114(6):728-33. PubMed ID: 2512365
    [Abstract] [Full Text] [Related]

  • 8. Complement deposition by antibodies to Pseudomonas aeruginosa mucoid exopolysaccharide (MEP) and by non-MEP specific opsonins.
    Pier GB, Grout M, Desjardins D.
    J Immunol; 1991 Sep 15; 147(6):1869-76. PubMed ID: 1832427
    [Abstract] [Full Text] [Related]

  • 9. Pseudomonas respiratory infection in cystic fibrosis: a possible defect in opsonic IgG antibody?
    Fick RB, Reynolds HY.
    Bull Eur Physiopathol Respir; 1983 Sep 15; 19(2):151-61. PubMed ID: 6871494
    [Abstract] [Full Text] [Related]

  • 10. Mucoid Pseudomonas aeruginosa growing in a biofilm in vitro are killed by opsonic antibodies to the mucoid exopolysaccharide capsule but not by antibodies produced during chronic lung infection in cystic fibrosis patients.
    Meluleni GJ, Grout M, Evans DJ, Pier GB.
    J Immunol; 1995 Aug 15; 155(4):2029-38. PubMed ID: 7636254
    [Abstract] [Full Text] [Related]

  • 11. Correlation of serum opsonic activity in cystic fibrosis with colonization and disease state: measurement of opsonins to Pseudomonas aeruginosa by neutrophil superoxide anion generation.
    Bender JG, Florman AL, Van Epps DE.
    Pediatr Res; 1987 Oct 15; 22(4):383-8. PubMed ID: 2825106
    [Abstract] [Full Text] [Related]

  • 12. Rationale for development of immunotherapies that target mucoid Pseudomonas aeruginosa infection in cystic fibrosis patients.
    Pier GB.
    Behring Inst Mitt; 1997 Feb 15; (98):350-60. PubMed ID: 9382760
    [Abstract] [Full Text] [Related]

  • 13. Bispecific antibodies overcome the opsonin-receptor mismatch of cystic fibrosis in vitro: restoration of neutrophil-mediated phagocytosis and killing of Pseudomonas aeruginosa.
    McCormick LL, Karulin AY, Schreiber JR, Greenspan NS.
    J Immunol; 1997 Apr 01; 158(7):3474-82. PubMed ID: 9120309
    [Abstract] [Full Text] [Related]

  • 14. Pseudomonas aeruginosa chromosomal beta-lactamase in patients with cystic fibrosis and chronic lung infection. Mechanism of antibiotic resistance and target of the humoral immune response.
    Ciofu O.
    APMIS Suppl; 2003 Apr 01; (116):1-47. PubMed ID: 14692154
    [Abstract] [Full Text] [Related]

  • 15. Diagnostic significance of measurements of specific IgG antibodies to Pseudomonas aeruginosa by three different serological methods.
    Pressler T, Karpati F, Granström M, Knudsen PK, Lindblad A, Hjelte L, Olesen HV, Meyer P, Høiby N, Scandinavian CF Study Consortium.
    J Cyst Fibros; 2009 Jan 01; 8(1):37-42. PubMed ID: 18835753
    [Abstract] [Full Text] [Related]

  • 16. Pseudomonas aeruginosa infection in cystic fibrosis. Bactericidal effect of serum from normal individuals and patients with cystic fibrosis on P. aeruginosa strains from patients with cystic fibrosis or other diseases.
    Holby N, Olling S.
    Acta Pathol Microbiol Scand C; 1977 Apr 01; 85(2):107-14. PubMed ID: 404841
    [Abstract] [Full Text] [Related]

  • 17. [Anti-Pseudomonas aeruginosa antibodies, circulating immune complexes, and anticytoplasm antibodies of neutrophils in patients with cystic fibrosis with and without Pseudomonas aeruginosa colonization].
    Chiappini E, Taccetti G, Campana S, Turchini S, Marianelli L.
    Pediatr Med Chir; 2001 Apr 01; 23(1):27-30. PubMed ID: 11486418
    [Abstract] [Full Text] [Related]

  • 18. Correlation between specific IgG subclass antibodies to Pseudomonas aeruginosa and opsonic activity in serum from patients with cystic fibrosis.
    Pressler T, Jensen ET, Espersen F, Pedersen SS, Høiby N, Koch C.
    Pediatr Pulmonol; 1994 Jan 01; 17(1):31-40. PubMed ID: 8108174
    [Abstract] [Full Text] [Related]

  • 19. The immunoglobulin G subclass composition of immune complexes in cystic fibrosis. Implications for the pathogenesis of the Pseudomonas lung lesion.
    Hornick DB, Fick RB.
    J Clin Invest; 1990 Oct 01; 86(4):1285-92. PubMed ID: 2120286
    [Abstract] [Full Text] [Related]

  • 20. Immune complexes from immunized mice and infected cystic fibrosis patients mediate murine and human T cell killing of hybridomas producing protective, opsonic antibody to Pseudomonas aeruginosa.
    Pier GB, Takeda S, Grout M, Markham RB.
    J Clin Invest; 1993 Mar 01; 91(3):1079-87. PubMed ID: 8450038
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.